A significant increase in antimicrobial resistance among pneumococci causing invasive disease in New Zealand

New Zealand Medical Journal

Volumn 112, Issue 1085, 1999, Pages 113-115

  Brett, Maggie S ^a   Martin, Diana R ^a  

^a INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; PENICILLIN G;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NEW ZEALAND; NONHUMAN; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEW ZEALAND; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 0033538094     PISSN: 00288446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Klugman KP. Pneumococcal resitance to antibiotics. Clin Microbiol Rev 1990; 3: 171-96.
2. Baquero F. Pneumococcal resistance to β-lactam antibiotics: a global geographic overview. Microb Drug Resist 1995; 1: 115-20
3. Heffernan H. Antimicrobial susceptibility of clinically significant Streptococcus pneumoniae isolates. NZ Med J 1987; 100: 327.
4. Martin DR, Brett MS. Pneumococci causing invasive disease in New Zealand, 1987-94: serogroup and serotype coverage and antibiotic resistances. NZ Med J 1996; 107: 288-90.
5. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; Seventh Informational Supplement. NCCLS Document M100-S7. Villanova, Pennsylvania, NCCLS, 1998.
6. Butler JC, Hofmann J, Cetron MS et al. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centres for Disease Control and Prevention's Pneumococcal Sentinel Surveillance system. J Infect Dis 1996; 174: 986-93.
7. Kayty H, Eskola J. New vaccines for the prevention of pneumococcal infections. Emerg Infect Dis 1996; 2: 289-94.
8. Scott JAG, Hall AJ, Dagan R et al. Serogroup-specific epidemiology of Steptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease. Clin Infect Dis 1996; 22: 973-81.
9. Burman LA, Norrby R, Trollfors B. Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. Rev Infect Dis 1985; 7: 133-42.
10. Kertesz DA, Di Fabio JL, de Cunto Brandileone MC, et al. Invasive Streptococcus pneumoniae infection in Latin American children: results of the Pan American Health Organization Surveillance study. Clin Infect Dis 1998; 1355-61.
11. Colman G, Cooke EM, Cookson BD et al. Pneumococci causing invasive disease in Britain 1982-1990. J Med Microbiol 1998; 47: 17-27.
12. Jorgensen JH, Ferraro MJ, McElmeel L et al. Detection of penicillin and extended-spectrum cephlosporin resistance among Streptococcus pneumoniae clinical isolates by use of the E test. J Clin Microbiol 1994; 32: 159-63.
13. Thorvilson J, Kohner P, Henry N, Cockerill F. Comparison of agar dilution, broth dilution, disk diffusion and the E-test for susceptibility testing of penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis 1997; 16: 391-4.
14. Breiman RF, Butler JC, Tenover FC et al. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994; 271: 1831-5.
15. Gratten M, Torzillo P, Morey F et al. Distribution of capsular types and antibiotic susceptibility of invasive Streptococcus pneumoniae isolated from aborigines in Central Australia. J Clin Microbiol 1996; 34: 338-41.
16. Soares S, Kristinsson KG, Musser JM et al. Evidence for the introduction of multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. J Infect Dis 1993; 168: 158-63.
17. Munoz R, Coffey TJ, Daniels M et al. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J Infect Dis 1991; 164: 302-6.
18. Kristinsson KG. Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci. Microb Drug Resist 1997; 3: 117-23.